Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 559-564

  Akridge, Robert E ^a   Reed, Steven G ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030019853     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.559     Document Type: Article

References (30)

1. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of a natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989; 170:82745.
2. Stem AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytokine lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Nail Acad Sci USA 1990; 87:6808-12.
3. Brunda MJ. IL-12. J Leukocyte Biol 1994;55:280-8.
4. Wolf SF, Sieburth D, Sypek J. Interleukin 12: a key modulator of immune function. Stem Cell 1994;12:154-68.
5. Morris SC, Madden KB, Adamovicz JJ, et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994;152:1047-56.
6. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science 1993;260:496-7.
7. Clerici M, Lucey DR, Berzofsky JA, et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-4.
8. Chehimi J, Starr SE, Frank I, et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-6.
9. Merrill JE, Koyanagi Y, Chen IS. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63:4404-8.
10. Reed SG, da Silva JS, Ho JL, et al. Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. J AIDS 1992;5:666-5.
11. Wahl SM, Allen JB, Gartner S, et al. Human immunodeficiency virus-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol 1989;142:3553-9.
12. Zembala M, Asherson GL. Human monocytes. San Diego: Academic Press, 1989:291-301.
13. Gartner S, Markovits P, Markovitz DM, Betts RF, Popvic M. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986;256:2365-71.
14. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popvic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-9.
15. Ba-L- Effect on accessory cell function for T-cell proliferation in vitro. AIDS Res Hum Retroviruses 1991;7:465-74.
16. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988;167:1428-41.
17. BaL Effect on cell surface expression of CD4, CD14, HLA-DR, and HLA-DQ. AIDS Res Hurn Retroviruses 1990; 6:731-41.
18. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
19. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G. Mechanism of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). J Immunol 1992;148:92-8.
20. Francis ML, Meltzer MS, Gendelman HE. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res Hum Retroviruses 1992;8:199-207.
21. Germann T, Gately MK, Schoenhaut DS, et al. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (TH1) but not TH2 cells. Eur J Immunol 1993;23:1762-70.
22. Robertson MJ, Soiffer RJ, Wolf SF, et al. Response of human natural killer cells to natural killer cell stimulatory factor: cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992;175:779-88.
23. Sypek JP, Chung CL, Mayor SEH, et al. Resolution of cutaneous leishmanasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
24. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major, J Exp Med 1993;177:1505-9.
25. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin-12 is required for T-lymphocyte-independent induction of interferon by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-9.
26. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178:56777.
27. Butera ST, Roberts BD, Leung K, Nabel GJ, Folks TM. Tumor necrosis factor receptor expression and signal transduction in HIV-1-infected cells. AIDS 1993;7:911-8.
28. Koyanagi Y, O'Brien WA, Zhao JQ, et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988;241:16735.
29. Matsuyama T, Kobayashi N, Yamamoto N. Cytokine and HIV infection. Is AIDS a tumor necrosis factor disease? AIDS 1991;5:1405-17.
30. Poli G, Fauci A. The effects of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7.